Saniona announced appointment of Jason A. Amello as Chief Financial Officer. Jason A. Amello has over 25 years of corporate finance experience in the biopharmaceutical industry, contributing to strategic business growth and financial and operational performance. Most recently he served as Senior Vice President, Chief Financial Officer and Treasurer of Akebia Therapeutics Inc., where, over a seven-year period, he helped lead Akebia's financing efforts, including its initial public offering, and served as a key advisor for Akebia's merger with Keryx Biopharmaceuticals. During his tenure at Akebia, Amello built out the entire finance organization and was responsible for treasury management, financial planning and budgeting, accounting and reporting, taxation, procurement, facilities, and information technology. Prior to joining Akebia, Amello served as Executive Vice President, Chief Financial Officer and Treasurer of Ziopharm Oncology Inc., and prior to that he held multiple finance leadership positions at Genzyme Corporation, now Sanofi Genzyme, including Senior Vice President, Chief Accounting Officer.